Rare diseases
Investigational molecules
Locations
Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
The NetherlandsStudy of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden
The NetherlandsStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
The NetherlandsStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
The NetherlandsStudy on the Effects of Obicetrapib and Ezetimibe on Coronary Plaque in Patients with Atherosclerotic Cardiovascular Disease
The NetherlandsStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
The NetherlandsStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
The NetherlandsStudy on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis
The NetherlandsStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
The NetherlandsStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
The NetherlandsStudy on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)
The NetherlandsStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
